MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing revolutionizes the diagnosis and management of CCLFHDD, aiding in personalized care, informed family planning, and advancing research.
CIPA, a rare genetic disorder impeding pain sensation and sweating, is diagnosed via genetic testing. Early detection aids management and guides family planning.
Unlock the potential of genetic testing in diagnosing CMS11. Identify RAPSN mutations, ensure accurate diagnoses, personalized treatments, and informed family planning.
Explore how genetic testing revolutionizes CMS17 diagnosis with precise mutation identification, personalized treatments, and informed family planning options.
Explore the impact of genetic testing in diagnosing and managing Congenital Myasthenic Syndrome 18, guiding personalized treatment and aiding family planning.
Discover how genetic testing identifies and manages Congenital Myasthenic Syndrome 2A by confirming RAPSN gene mutations, guiding treatment, and aiding family planning.
Unlock the potential of genetic testing in diagnosing CMS 2C. Early diagnosis, personalized treatment, and genetic counseling offer hope to families affected by this rare disorder.
Explore Congenital Myasthenic Syndrome 3A, genetic testing's impact on diagnosis, treatment options, and family planning. Learn about RAPSN gene mutation's role.